Improving the development of cancer biomarkers using advanced statistical methods
Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies
This study is working on new ways to improve cancer tests and treatments, so patients can get more accurate and quicker results, helping them find and fight cancer better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10993177 on NIH RePORTER |
What this research studies
This research focuses on enhancing the development and validation of cancer biomarkers, which are crucial for precision medicine. By creating innovative statistical tools, the project aims to streamline the analysis of phase III and IV studies, making it easier to assess the effectiveness of cancer screening and treatment. The methods will help combine data from different studies and improve the design of clinical trials, ultimately leading to faster and more reliable biomarker validation. Patients may benefit from more accurate and timely cancer detection and treatment options as a result of this work.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals undergoing cancer screening or treatment who may benefit from improved biomarker development.
Not a fit: Patients with cancers that are not being studied or those who are not eligible for current biomarker trials may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to quicker and more effective cancer detection and treatment options for patients.
How similar studies have performed: Other research has shown success in using advanced statistical methods to improve biomarker validation, indicating that this approach has potential for significant impact.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Huang, Ying — Fred Hutchinson Cancer Center
- Study coordinator: Huang, Ying
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.